European Society for Medical Oncology (ESMO) shared a post on LinkedIn:
“Will AI reduce or increase inequities in cancer care?
As artificial intelligence becomes more embedded in oncology, questions around bias, access, and ethics are gaining urgency.
In his latest column for the ESMO Daily Reporter, Dario Trapani explores the ethical frontier of AI-driven oncology and challenges clinicians, researchers, policy makers to consider: who benefits, and who might be left behind?
Read the full article.”
More posts featuring European Society for Medical Oncology.